Research Papers

25 of 91 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Central nervous system (CNS) inflammatory demyelinating diseases (IDDs) associated with COVID-19: A case series and rev…
Feizi P; Sharma K; Pasham SR; Nirwan L; Joseph J; Jaiswal S; Sriwastava S.
J Neuroimmunol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) following SARS-CoV-2 infection: A case series.
Lambe J; McGinley MP; Moss BP; Mao-Draayer Y; Kassa R; Ciotti JR; Mariotto S; Kunchok A.
J Neuroimmunol (Unknown)
Published: 2022
1/6 Transparent
Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab.
Adamec I; Rogić D; Penz MG; Braun C; Habek M.
J Neuroimmunol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Stellate ganglion block reduces symptoms of Long COVID: A case series.
Liu LD; Duricka DL.
J Neuroimmunol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
A systematic review of cases of CNS demyelination following COVID-19 vaccination.
Ismail II; Salama S.
J Neuroimmunol (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Initial clinical manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine.
Fujimori J; Miyazawa K; Nakashima I.
J Neuroimmunol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cro…
Achiron A; Mandel M; Dreyer-Alster S; Harari G; Dolev M; Menascu S; Magalashvili D; Flechter S; Givon U; Guber D; Sonis P; Zilkha-Falb R; Gurevich M.
J Neuroimmunol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
The microglial NLRP3 inflammasome is involved in human SARS-CoV-2 cerebral pathogenicity: A report of three post-mortem…
Cama VF; Marín-Prida J; Acosta-Rivero N; Acosta EF; Díaz LO; Casadesús AV; Fernández-Marrero B; Gilva-Rodríguez N; Cremata-García D; Cervantes-Llanos M; Piniella-Matamoros B; Sánchez D; Del Rosario-Cruz L; Borrajero I; Díaz A; González Y; Pentón-Arias E; Montero-González T; Guillen-Nieto G; Pentón-Rol G.
J Neuroimmunol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Humoral immune response in convalescent COVID-19 people with multiple sclerosis treated with high-efficacy disease-modi…
Habek M; Jakob Brecl G; Bašić Kes V; Rogić D; Barun B; Gabelić T; Emeršič A; Horvat Ledinek A; Grbić N; Lapić I; Šegulja D; Đurić K; Adamec I; Krbot Skorić M.
J Neuroimmunol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature.
Min YG; Ju W; Ha YE; Ban JJ; Lee SA; Sung JJ; Shin JY.
J Neuroimmunol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms.
Johansson A; Mohamed MS; Moulin TC; Schiöth HB.
J Neuroimmunol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Complex movement disorders in SARS-CoV-2 infection induced acute disseminated encephalomyelitis.
Ghosh R; Dubey S; Mandal A; Ray BK; Benito-León J.
J Neuroimmunol (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
A case of longitudinally extensive transverse myelitis following vaccination against Covid-19.
Pagenkopf C; Südmeyer M.
J Neuroimmunol (Unknown)
Published: 2021
2/6 Transparent
Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consens…
Reyes S; Cunningham AL; Kalincik T; Havrdová EK; Isobe N; Pakpoor J; Airas L; Bunyan RF; van der Walt A; Oh J; Mathews J; Mateen FJ; Giovannoni G.
J Neuroimmunol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients.
Kelly H; Sokola B; Abboud H.
J Neuroimmunol (Unknown)
Published: 2021
1/6 Transparent
Guillain-Barré syndrome associated with SARS-CoV-2 infection: A case report with long term follow up.
Papri N; Hayat S; Mohammed A; Afsar MNA; Hasan I; Rahman A; Jahan I; Islam Z.
J Neuroimmunol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
A case of area postrema variant of neuromyelitis optica spectrum disorder following SARS-CoV-2 infection.
Ghosh R; De K; Roy D; Mandal A; Biswas S; Biswas S; Sengupta S; Naga D; Ghosh M; Benito-León J.
J Neuroimmunol (Unknown)
Published: 2020
COVID-19 associated with sensorimotor polyradiculoneuropathy and skin lesions: A case report.
Boostani R; Talab FR; Meibodi NT; Zemorshidi F.
J Neuroimmunol (Unknown)
Published: 2020
1/6 Transparent
Bilateral thalamic changes in anti-NMDAR encephalitis presenting with hemichorea and dystonia and acute transient psych…
Dubey S; Ghosh R; Dubey MJ; Sengupta S; Benito-León J; Ray BK.
J Neuroimmunol (Unknown)
Published: 2020
1/6 Transparent
Funding Declared
The peripheral blood immune cell profile in a teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia.
Ciardi MR; Zingaropoli MA; Pasculli P; Perri V; Tartaglia M; Valeri S; Russo G; Conte A; Mastroianni CM.
J Neuroimmunol (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
LGI1-antibody associated epilepsy successfully treated in the outpatient setting.
Uribe-San-Martín R; Ciampi E; Santibañez R; Irani SR; Márquez A; Cruz JP; Soler B; Miranda MC; Henríquez M; Cárcamo C.
J Neuroimmunol (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders.
Maddison P; Titulaer MJ; Verschuuren JJ; Gozzard P; Lang B; Irani SR; Sabater L; Graus F; Murray A; Chapman CJ.
J Neuroimmunol (Unknown)
Published: 2018
2/6 Transparent
Funding Declared
Elevated serum levels of IL-6 and CXCL9 in autoimmune retinopathy (AIR) patients.
Detrick B; Gangaputra S; Palsgrove DN; Heaney CD; Hooks JJ; Nida Sen H.
J Neuroimmunol (Unknown)
Published: 2017
Viral-induced suppression of self-reactive T cells: Lessons from neurotropic coronavirus-induced demyelination.
Savarin C; Bergmann CC.
J Neuroimmunol (Unknown)
Published: 2017
1/6 Transparent
Funding Declared
Roles of regulatory T cells and IL-10 in virus-induced demyelination.
Perlman S; Zhao J.
J Neuroimmunol (Unknown)
Published: 2017
1/6 Transparent
Funding Declared